Esther Pena

Statistics

Publications

Citations

H-Index

Active since

2011

Affiliations

Complejo Hospitalario de Navarra(Current)

Hospital San Pedro

Research Institute Hospital 12 de Octubre

Navarre Institute of Health Research

Universidad de Navarra

Esther Pena is an author at Complejo Hospitalario de Navarra specializing in rituximab-based therapy, antibody-dependent cellular cytotoxicity, and monoclonal antibodies.

ORCID

Publications per year

2011–2020

Publications

Follicular lymphoma: in vitro effects of combining lymphokine-activated killer (LAK) cell-induced cytotoxicity and rituximab- and obinutuzumab-dependent cellular cytotoxicity (ADCC) activity

Ricardo García‐Muñoz, Ascensión López-Dı́az de Cerio, Jesús Feliu et al. · Immunologic Research · 2015 · 16 citations

Life Sciences, Hematology, Immunology +16

Improved traceability and transfusion safety with a new portable computerised system in a hospital with intermediate transfusion activity.

María Jose Uríz, María Luisa Antelo, Saioa Zalba et al. · PubMed · 2011 · 12 citations · Full text

Health Professions, Biomedical Informatics, Health Informatics +17

Maintenance therapy with <i>ex vivo</i> expanded lymphokine‐activated killer cells and rituximab in patients with follicular lymphoma is safe and may delay disease progression

Ascensión López-Dı́az de Cerio, Ricardo García‐Muñoz, Esther Pena et al. · British Journal of Haematology · 2020 · 11 citations · Full text

Medicine, Hematology, Immunology +16

1–3 of 3